| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cargo receptor activity | 3.37e-08 | 85 | 116 | 8 | GO:0038024 | |
| GeneOntologyMolecularFunction | calcium ion binding | GNPTAB BCAN CUBN PKD1L2 LRP1B F12 CRB1 DST HMCN2 UMODL1 LRP1 LRP2 LRP4 EGFLAM LTBP2 AGRN DNASE1L2 NOTCH1 | 3.16e-07 | 749 | 116 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.86e-06 | 16 | 116 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.61e-06 | 156 | 116 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.00e-06 | 21 | 116 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.71e-05 | 27 | 116 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 6.64e-05 | 14 | 116 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 8.26e-05 | 15 | 116 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 1.01e-04 | 16 | 116 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.46e-04 | 18 | 116 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.03e-04 | 20 | 116 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 2.03e-04 | 20 | 116 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | inhibin binding | 3.31e-04 | 5 | 116 | 2 | GO:0034711 | |
| GeneOntologyMolecularFunction | microfibril binding | 4.94e-04 | 6 | 116 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | protease binding | 6.64e-04 | 181 | 116 | 6 | GO:0002020 | |
| GeneOntologyMolecularFunction | lipoteichoic acid binding | 6.89e-04 | 7 | 116 | 2 | GO:0070891 | |
| GeneOntologyMolecularFunction | coreceptor activity | 8.21e-04 | 72 | 116 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.64e-04 | 73 | 116 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.00e-03 | 34 | 116 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | activin receptor activity | 1.17e-03 | 9 | 116 | 2 | GO:0017002 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.52e-03 | 85 | 116 | 4 | GO:0001618 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.52e-03 | 85 | 116 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.59e-03 | 86 | 116 | 4 | GO:0140272 | |
| GeneOntologyMolecularFunction | hemoglobin binding | 1.78e-03 | 11 | 116 | 2 | GO:0030492 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.86e-03 | 42 | 116 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | activin binding | 2.13e-03 | 12 | 116 | 2 | GO:0048185 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.50e-03 | 13 | 116 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 2.73e-03 | 48 | 116 | 3 | GO:0001530 | |
| GeneOntologyMolecularFunction | hormone binding | 3.07e-03 | 103 | 116 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | integrin binding | 3.58e-03 | 175 | 116 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 3.03e-05 | 2 | 114 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 5.61e-05 | 74 | 114 | 5 | GO:0042733 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 5.73e-05 | 14 | 114 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | regionalization | MKKS WNT7A ACVR2A ACVR2B TDRD1 C2CD3 GLI1 LRP2 LRP4 IFT122 NOTCH1 | 6.94e-05 | 478 | 114 | 11 | GO:0003002 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 7.13e-05 | 15 | 114 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.00e-04 | 334 | 114 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.00e-04 | 334 | 114 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 1.05e-04 | 262 | 114 | 8 | GO:0048771 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | MKKS WNT7A ACVR2A ACVR2B PLXNB2 C2CD3 GLI1 EPHA2 LRP2 LRP4 IFT122 TNFAIP3 NOTCH1 | 1.58e-04 | 713 | 114 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | pattern specification process | MKKS WNT7A ACVR2A ACVR2B TDRD1 C2CD3 GLI1 LRP2 LRP4 IFT122 NOTCH1 | 1.61e-04 | 526 | 114 | 11 | GO:0007389 |
| GeneOntologyCellularComponent | cell surface | DPP4 VWF SEMA7A WNT7A RAET1E BCAN TNFRSF11A ACVR2A CUBN PLXNB2 ITGB3 CD6 CLCN3 UMODL1 CD163L1 EPHA2 LPA LRP1 LRP2 LRP4 CORIN TRPM8 MDGA1 AGRN NOTCH1 | 2.37e-09 | 1111 | 118 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 VWF SEMA7A WNT7A BCAN PLXNB2 F12 LGALS3BP TRIL DST HMCN2 LPA EGFLAM LTBP2 DMBT1 AGRN ADAMTSL2 | 1.65e-07 | 656 | 118 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 VWF SEMA7A WNT7A BCAN PLXNB2 F12 LGALS3BP TRIL DST HMCN2 LPA EGFLAM LTBP2 DMBT1 AGRN ADAMTSL2 | 1.73e-07 | 658 | 118 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 VWF SEMA7A BCAN PLXNB2 F12 LGALS3BP DST HMCN2 LPA EGFLAM LTBP2 DMBT1 AGRN | 1.78e-06 | 530 | 118 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | side of membrane | LYPD6 VWF RNF31 SEMA7A RAET1E BCAN TNFRSF11A CUBN ITGB3 DST CLCN3 UMODL1 CD163L1 LPA LRP1 LRP2 TRPM8 MDGA1 | 1.99e-06 | 875 | 118 | 18 | GO:0098552 |
| GeneOntologyCellularComponent | receptor complex | AMHR2 RNF31 ACVR2A ACVR2B CUBN PLXNB2 LRP1B ITGB3 TRIL CD6 EPHA2 LRP1 LRP2 NOTCH1 | 5.16e-06 | 581 | 118 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | external side of plasma membrane | VWF SEMA7A RAET1E TNFRSF11A CUBN ITGB3 CLCN3 UMODL1 CD163L1 LPA LRP1 LRP2 TRPM8 | 7.58e-06 | 519 | 118 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.50e-04 | 22 | 118 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | activin receptor complex | 4.67e-04 | 6 | 118 | 2 | GO:0048179 | |
| GeneOntologyCellularComponent | basement membrane | 6.45e-04 | 122 | 118 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | synaptic cleft | 8.45e-04 | 33 | 118 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.10e-03 | 80 | 118 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | axon | CNTNAP3B CNTNAP3 BCAN ADAM22 EXOC8 ADRA2C DST HMCN2 CLCN3 LRP1 LRP2 MDGA1 AGRN | 1.57e-03 | 891 | 118 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | NSL complex | 1.68e-03 | 11 | 118 | 2 | GO:0044545 | |
| GeneOntologyCellularComponent | synaptic membrane | ADGRB3 BCAN ITGB3 ADAM22 ADRA2C CLCN3 LRP1 CNTNAP4 LRP4 NOTCH1 | 1.73e-03 | 583 | 118 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.98e-03 | 157 | 118 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.09e-03 | 45 | 118 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.40e-03 | 164 | 118 | 5 | GO:0098982 | |
| Domain | EGF_2 | CNTNAP3B LAMB4 CNTNAP3 BCAN CUBN LRP1B ITGB3 ADAM22 F12 CRB1 HMCN2 UMODL1 EPHA2 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 9.44e-19 | 265 | 117 | 22 | PS01186 |
| Domain | EGF_1 | CNTNAP3B LAMB4 CNTNAP3 BCAN CUBN LRP1B ITGB3 ADAM22 F12 CRB1 HMCN2 UMODL1 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 7.39e-18 | 255 | 117 | 21 | PS00022 |
| Domain | EGF-like_CS | LAMB4 CNTNAP3 BCAN CUBN LRP1B ITGB3 ADAM22 F12 CRB1 HMCN2 UMODL1 EPHA2 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 1.19e-17 | 261 | 117 | 21 | IPR013032 |
| Domain | EGF_3 | CNTNAP3B CNTNAP3 BCAN CUBN LRP1B ADAM22 F12 CRB1 HMCN2 UMODL1 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 4.39e-16 | 235 | 117 | 19 | PS50026 |
| Domain | EGF-like_dom | CNTNAP3B CNTNAP3 BCAN CUBN LRP1B ADAM22 F12 CRB1 HMCN2 UMODL1 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 1.28e-15 | 249 | 117 | 19 | IPR000742 |
| Domain | EGF | CNTNAP3 BCAN CUBN LRP1B ITGB3 F12 CRB1 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 | 2.06e-15 | 126 | 117 | 15 | PF00008 |
| Domain | EGF | CNTNAP3B CNTNAP3 BCAN CUBN LRP1B ADAM22 F12 CRB1 UMODL1 LRP1 CNTNAP4 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 MEGF10 | 7.16e-15 | 235 | 117 | 18 | SM00181 |
| Domain | EGF_CA | CUBN LRP1B F12 CRB1 HMCN2 UMODL1 LRP1 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 | 7.17e-13 | 122 | 117 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | CUBN LRP1B F12 CRB1 HMCN2 UMODL1 LRP1 LRP2 LRP4 EGFLAM LTBP2 AGRN NOTCH1 | 8.87e-13 | 124 | 117 | 13 | IPR001881 |
| Domain | SR | 1.38e-10 | 25 | 117 | 7 | SM00202 | |
| Domain | SRCR-like_dom | 1.88e-10 | 26 | 117 | 7 | IPR017448 | |
| Domain | SRCR_1 | 1.88e-10 | 26 | 117 | 7 | PS00420 | |
| Domain | SRCR_2 | 1.88e-10 | 26 | 117 | 7 | PS50287 | |
| Domain | SRCR | 2.53e-10 | 27 | 117 | 7 | IPR001190 | |
| Domain | EGF_Ca-bd_CS | 5.01e-10 | 97 | 117 | 10 | IPR018097 | |
| Domain | EGF_CA | 6.15e-10 | 99 | 117 | 10 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.79e-10 | 100 | 117 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.21e-09 | 106 | 117 | 10 | IPR000152 | |
| Domain | SRCR | 2.67e-09 | 21 | 117 | 6 | PF00530 | |
| Domain | EGF_CA | 3.34e-09 | 86 | 117 | 9 | PF07645 | |
| Domain | Growth_fac_rcpt_ | CUBN LRP1B CRB1 HMCN2 UMODL1 EPHA2 LRP1 LRP2 LRP4 LTBP2 NOTCH1 | 3.93e-09 | 156 | 117 | 11 | IPR009030 |
| Domain | LDLR_class-A_CS | 4.96e-09 | 40 | 117 | 7 | IPR023415 | |
| Domain | - | 8.53e-09 | 25 | 117 | 6 | 3.10.250.10 | |
| Domain | - | 1.38e-08 | 46 | 117 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.88e-08 | 48 | 117 | 7 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.18e-08 | 49 | 117 | 7 | IPR002172 | |
| Domain | LDLa | 2.18e-08 | 49 | 117 | 7 | SM00192 | |
| Domain | LDLRA_2 | 2.18e-08 | 49 | 117 | 7 | PS50068 | |
| Domain | EGF_extracell | 9.27e-08 | 60 | 117 | 7 | IPR013111 | |
| Domain | EGF_2 | 9.27e-08 | 60 | 117 | 7 | PF07974 | |
| Domain | LAM_G_DOMAIN | 1.24e-07 | 38 | 117 | 6 | PS50025 | |
| Domain | LamG | 3.09e-07 | 44 | 117 | 6 | SM00282 | |
| Domain | Ldl_recept_a | 3.54e-07 | 45 | 117 | 6 | PF00057 | |
| Domain | Ldl_recept_b | 1.39e-06 | 14 | 117 | 4 | PF00058 | |
| Domain | LDLRB | 1.39e-06 | 14 | 117 | 4 | PS51120 | |
| Domain | Laminin_G | 1.65e-06 | 58 | 117 | 6 | IPR001791 | |
| Domain | LY | 1.89e-06 | 15 | 117 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.89e-06 | 15 | 117 | 4 | IPR000033 | |
| Domain | - | 4.30e-06 | 39 | 117 | 5 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 4.89e-06 | 40 | 117 | 5 | PF02210 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.88e-06 | 46 | 117 | 5 | IPR011042 | |
| Domain | cEGF | 1.97e-05 | 26 | 117 | 4 | PF12662 | |
| Domain | cEGF | 1.97e-05 | 26 | 117 | 4 | IPR026823 | |
| Domain | Activin_recp | 2.78e-05 | 10 | 117 | 3 | PF01064 | |
| Domain | Activin_recp | 2.78e-05 | 10 | 117 | 3 | IPR000472 | |
| Domain | DUF5050 | 3.89e-05 | 2 | 117 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.89e-05 | 2 | 117 | 2 | PF16472 | |
| Domain | TGFB_receptor | 5.06e-05 | 12 | 117 | 3 | IPR000333 | |
| Domain | OA_transporter | 5.06e-05 | 12 | 117 | 3 | IPR004156 | |
| Domain | OATP | 5.06e-05 | 12 | 117 | 3 | PF03137 | |
| Domain | Kazal_2 | 7.38e-05 | 36 | 117 | 4 | PF07648 | |
| Domain | KAZAL_2 | 2.70e-04 | 50 | 117 | 4 | PS51465 | |
| Domain | Kazal_dom | 2.91e-04 | 51 | 117 | 4 | IPR002350 | |
| Domain | FA58C | 2.93e-04 | 21 | 117 | 3 | SM00231 | |
| Domain | FA58C_3 | 2.93e-04 | 21 | 117 | 3 | PS50022 | |
| Domain | FA58C_1 | 2.93e-04 | 21 | 117 | 3 | PS01285 | |
| Domain | FA58C_2 | 2.93e-04 | 21 | 117 | 3 | PS01286 | |
| Domain | - | 3.27e-04 | 95 | 117 | 5 | 2.60.120.200 | |
| Domain | CUB | 3.38e-04 | 53 | 117 | 4 | PS01180 | |
| Domain | LNR | 3.84e-04 | 5 | 117 | 2 | PS50258 | |
| Domain | F5_F8_type_C | 4.41e-04 | 24 | 117 | 3 | PF00754 | |
| Domain | FA58C | 4.41e-04 | 24 | 117 | 3 | IPR000421 | |
| Domain | CUB_dom | 4.47e-04 | 57 | 117 | 4 | IPR000859 | |
| Domain | ConA-like_dom | 4.61e-04 | 219 | 117 | 7 | IPR013320 | |
| Domain | hEGF | 7.00e-04 | 28 | 117 | 3 | PF12661 | |
| Domain | Notch_dom | 8.00e-04 | 7 | 117 | 2 | IPR000800 | |
| Domain | SRCR_2 | 8.00e-04 | 7 | 117 | 2 | PF15494 | |
| Domain | Notch | 8.00e-04 | 7 | 117 | 2 | PF00066 | |
| Domain | NL | 8.00e-04 | 7 | 117 | 2 | SM00004 | |
| Domain | FIBRINOGEN_C_1 | 1.04e-03 | 32 | 117 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.04e-03 | 32 | 117 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.04e-03 | 32 | 117 | 3 | PS51406 | |
| Domain | PHD | 1.26e-03 | 75 | 117 | 4 | PF00628 | |
| Domain | EGF_Lam | 1.35e-03 | 35 | 117 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.35e-03 | 35 | 117 | 3 | PF00053 | |
| Domain | Znf_PHD-finger | 1.53e-03 | 79 | 117 | 4 | IPR019787 | |
| Domain | Laminin_EGF | 1.72e-03 | 38 | 117 | 3 | IPR002049 | |
| Domain | Laminin_G_1 | 2.06e-03 | 11 | 117 | 2 | PF00054 | |
| Domain | PHD | 2.37e-03 | 89 | 117 | 4 | SM00249 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.46e-03 | 12 | 117 | 2 | IPR011041 | |
| Domain | Znf_PHD | 2.57e-03 | 91 | 117 | 4 | IPR001965 | |
| Domain | PSI | 2.63e-03 | 44 | 117 | 3 | IPR016201 | |
| Domain | Galactose-bd-like | 2.89e-03 | 94 | 117 | 4 | IPR008979 | |
| Domain | PSI | 2.99e-03 | 46 | 117 | 3 | SM00423 | |
| Domain | KAZAL | 2.99e-03 | 46 | 117 | 3 | SM00280 | |
| Domain | ZF_PHD_2 | 3.00e-03 | 95 | 117 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 3.12e-03 | 96 | 117 | 4 | PS01359 | |
| Domain | TIL_dom | 3.37e-03 | 14 | 117 | 2 | IPR002919 | |
| Domain | ZP_2 | 3.37e-03 | 14 | 117 | 2 | PS51034 | |
| Domain | ZP_1 | 3.37e-03 | 14 | 117 | 2 | PS00682 | |
| Domain | CUB | 3.58e-03 | 49 | 117 | 3 | PF00431 | |
| Domain | CUB | 3.79e-03 | 50 | 117 | 3 | SM00042 | |
| Domain | ZP | 3.87e-03 | 15 | 117 | 2 | SM00241 | |
| Domain | TRYPSIN_HIS | 4.02e-03 | 103 | 117 | 4 | IPR018114 | |
| Domain | - | 4.24e-03 | 52 | 117 | 3 | 2.60.120.290 | |
| Domain | EMI_domain | 4.41e-03 | 16 | 117 | 2 | IPR011489 | |
| Domain | TRYPSIN_SER | 4.45e-03 | 106 | 117 | 4 | PS00135 | |
| Domain | TRYPSIN_HIS | 4.60e-03 | 107 | 117 | 4 | PS00134 | |
| Domain | MFS | 4.75e-03 | 108 | 117 | 4 | PS50850 | |
| Domain | Kringle_CS | 4.98e-03 | 17 | 117 | 2 | IPR018056 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | CUBN LRP1B LGALS3BP CD6 LRP10 CD163L1 LPA LRP1 LRP2 LRP4 TMPRSS2 HHIPL1 DMBT1 | 1.39e-06 | 381 | 94 | 13 | M48063 |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 6.05e-05 | 12 | 94 | 3 | MM15476 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.23e-04 | 15 | 94 | 3 | MM15697 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.24e-04 | 45 | 94 | 4 | MM15344 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 2.57e-04 | 19 | 94 | 3 | MM14612 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.88e-04 | 48 | 94 | 4 | M27642 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.01e-04 | 20 | 94 | 3 | MM14721 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GNPTAB CNTNAP3 TM2D3 PLXNB2 LRP1B ADAM22 LGALS3BP TPCN1 TM9SF2 LRP10 EPHA2 LRP1 LRP4 UHRF1 LTBP2 PLOD2 AGRN NOTCH1 DCAF12 | 2.37e-08 | 1201 | 118 | 19 | 35696571 |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 18296417 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 18492796 | ||
| Pubmed | Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. | 3.81e-08 | 3 | 118 | 3 | 28389619 | |
| Pubmed | Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. | 3.81e-08 | 3 | 118 | 3 | 23986199 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 20949553 | ||
| Pubmed | Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1). | 3.81e-08 | 3 | 118 | 3 | 18263616 | |
| Pubmed | Synergistic interaction between genetics and disease on pravastatin disposition. | 3.81e-08 | 3 | 118 | 3 | 24613363 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 10833452 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 30955241 | ||
| Pubmed | Influence of drug formulation on OATP1B-mediated transport of paclitaxel. | 3.81e-08 | 3 | 118 | 3 | 24755470 | |
| Pubmed | OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. | 3.81e-08 | 3 | 118 | 3 | 29337310 | |
| Pubmed | Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model. | 3.81e-08 | 3 | 118 | 3 | 31967785 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 18413659 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 19400585 | ||
| Pubmed | 4.08e-08 | 11 | 118 | 4 | 24639464 | ||
| Pubmed | Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. | 8.79e-08 | 13 | 118 | 4 | 16207730 | |
| Pubmed | Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. | 1.52e-07 | 4 | 118 | 3 | 22294745 | |
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 20644253 | ||
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 25280775 | ||
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 33576766 | ||
| Pubmed | Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. | 1.52e-07 | 4 | 118 | 3 | 27777271 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 3.71e-07 | 18 | 118 | 4 | 23696569 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 24194565 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 19047013 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 7.21e-07 | 21 | 118 | 4 | 21337463 | |
| Pubmed | A20 controls RANK-dependent osteoclast formation and bone physiology. | 7.56e-07 | 6 | 118 | 3 | 36194667 | |
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 22232210 | ||
| Pubmed | Analysis of DNA methylation and histone modification profiles of liver-specific transporters. | 7.56e-07 | 6 | 118 | 3 | 19047482 | |
| Pubmed | 1.75e-06 | 167 | 118 | 7 | 22159717 | ||
| Pubmed | 2.39e-06 | 175 | 118 | 7 | 28071719 | ||
| Pubmed | 3.09e-06 | 117 | 118 | 6 | 17145500 | ||
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 23986861 | ||
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 18703564 | ||
| Pubmed | Genes to diseases (G2D) computational method to identify asthma candidate genes. | 4.49e-06 | 10 | 118 | 3 | 18682798 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 21951552 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 11682476 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.14e-05 | 2 | 118 | 2 | 15963947 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22134168 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23978537 | ||
| Pubmed | Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. | 1.14e-05 | 2 | 118 | 2 | 9790192 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 29944058 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 38008818 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18791690 | ||
| Pubmed | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 1.14e-05 | 2 | 118 | 2 | 36964102 | |
| Pubmed | Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules. | 1.14e-05 | 2 | 118 | 2 | 27213360 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11994745 | ||
| Pubmed | Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins. | 1.14e-05 | 2 | 118 | 2 | 10766831 | |
| Pubmed | Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. | 1.14e-05 | 2 | 118 | 2 | 23340295 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20005200 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 29777022 | ||
| Pubmed | Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis. | 1.14e-05 | 2 | 118 | 2 | 26191226 | |
| Pubmed | Cubilin and megalin expression and their interaction in the rat intestine: effect of thyroidectomy. | 1.14e-05 | 2 | 118 | 2 | 11595644 | |
| Pubmed | Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney. | 1.14e-05 | 2 | 118 | 2 | 22437417 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26807827 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24194513 | ||
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 1.14e-05 | 2 | 118 | 2 | 22854782 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 32166996 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24855184 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12042312 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26474710 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25578040 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24989890 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21719246 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20877131 | ||
| Pubmed | Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. | 1.14e-05 | 2 | 118 | 2 | 8049070 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25038227 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16534140 | ||
| Pubmed | Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. | 1.14e-05 | 2 | 118 | 2 | 18321482 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37321467 | ||
| Pubmed | Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. | 1.14e-05 | 2 | 118 | 2 | 18045606 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15616221 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18314419 | ||
| Pubmed | OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. | 1.14e-05 | 2 | 118 | 2 | 21691816 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31150793 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 7748787 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34445520 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28063966 | ||
| Pubmed | Role of megalin and cubilin in the metabolism of vitamin D(3). | 1.14e-05 | 2 | 118 | 2 | 21595846 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22240838 | ||
| Pubmed | Differential distribution of cubilin and megalin expression in the mouse embryo. | 1.14e-05 | 2 | 118 | 2 | 14983511 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17412826 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24611720 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22771883 | ||
| Pubmed | Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans. | 1.14e-05 | 2 | 118 | 2 | 27197912 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18180273 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 9334227 | ||
| Pubmed | Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. | 1.14e-05 | 2 | 118 | 2 | 10073957 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37723174 | ||
| Pubmed | Formation and activation by phosphorylation of activin receptor complexes. | 1.14e-05 | 2 | 118 | 2 | 8721982 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18448595 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23670789 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28659341 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17496208 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23236639 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27098745 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24740327 | ||
| Pubmed | The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. | 1.14e-05 | 2 | 118 | 2 | 20392859 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 32661206 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 1318045 | ||
| Interaction | TGFBR1 interactions | DPP4 AMHR2 DCAF6 ACVR2B TGFBRAP1 EPHA2 LRP1 TMPRSS2 NOTCH1 DCAF12 | 2.47e-06 | 258 | 116 | 10 | int:TGFBR1 |
| Interaction | FBXO2 interactions | CNTNAP3B WNT7A GNPTAB CNTNAP3 TM2D3 PLXNB2 LRP1B LRP10 LRP2 IL17RA AGRN NOTCH1 | 4.49e-06 | 411 | 116 | 12 | int:FBXO2 |
| Interaction | ACVRL1 interactions | 4.58e-06 | 115 | 116 | 7 | int:ACVRL1 | |
| Interaction | IGFL3 interactions | 4.65e-06 | 75 | 116 | 6 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.01e-05 | 24 | 116 | 4 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.91e-05 | 57 | 116 | 5 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 2.46e-05 | 60 | 116 | 5 | int:ANKRD36B | |
| Interaction | RETSAT interactions | 3.41e-05 | 106 | 116 | 6 | int:RETSAT | |
| Interaction | SCGB1A1 interactions | 3.94e-05 | 12 | 116 | 3 | int:SCGB1A1 | |
| Interaction | DLK2 interactions | 5.32e-05 | 36 | 116 | 4 | int:DLK2 | |
| Interaction | CUBN interactions | 8.04e-05 | 15 | 116 | 3 | int:CUBN | |
| Cytoband | 5q33 | 9.76e-05 | 6 | 118 | 2 | 5q33 | |
| GeneFamily | Low density lipoprotein receptors | 3.41e-09 | 13 | 90 | 5 | 634 | |
| GeneFamily | Type 2 receptor serine/threonine kinases | 1.18e-06 | 5 | 90 | 3 | 346 | |
| GeneFamily | Tudor domain containing | 8.20e-04 | 37 | 90 | 3 | 780 | |
| GeneFamily | PHD finger proteins | 1.06e-03 | 90 | 90 | 4 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.51e-03 | 394 | 90 | 7 | 471 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 3.56e-03 | 18 | 90 | 2 | 498 | |
| Coexpression | NABA_MATRISOME | LAMB4 VWF SEMA7A WNT7A BCAN PLXNB2 ADAM22 F12 HMCN2 FGFBP2 LPA EGFLAM LTBP2 DMBT1 PLOD2 AGRN MEGF10 ADAMTSL2 | 7.82e-07 | 1026 | 118 | 18 | M5889 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | WNT7A GLIS3 ZMAT4 BCAN LRP1B LGALS3BP CRB1 TRIL DST LRP1 LRP2 CORIN PLOD2 | 1.98e-06 | 574 | 118 | 13 | M39056 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | VIPR2 WNT7A GLIS3 ANO5 BCAN TRIL ADRA2C EPHA2 LRP2 UHRF1 CORIN EGFLAM IL17RA MDGA1 PLOD2 GLIS1 NOTCH1 | 6.45e-06 | 1074 | 118 | 17 | M1941 |
| Coexpression | NABA_MATRISOME | VWF SEMA7A WNT7A BCAN PLXNB2 ADAM22 F12 HMCN2 LPA EGFLAM LTBP2 DMBT1 PLOD2 AGRN MEGF10 ADAMTSL2 | 1.20e-05 | 1008 | 118 | 16 | MM17056 |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_DN | 2.06e-05 | 36 | 118 | 4 | MM953 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.07e-05 | 196 | 118 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 3.58e-05 | 275 | 118 | 8 | M5884 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 3.34e-07 | 122 | 115 | 8 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.21e-08 | 183 | 118 | 8 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-08 | 185 | 118 | 8 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-08 | 196 | 118 | 8 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.36e-07 | 185 | 118 | 7 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 7.35e-07 | 189 | 118 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.35e-07 | 189 | 118 | 7 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-07 | 192 | 118 | 7 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-07 | 192 | 118 | 7 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-07 | 192 | 118 | 7 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.75e-07 | 194 | 118 | 7 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-07 | 195 | 118 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-07 | 195 | 118 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-06 | 199 | 118 | 7 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-06 | 200 | 118 | 7 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.57e-06 | 146 | 118 | 6 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 160 | 118 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 160 | 118 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.86e-06 | 163 | 118 | 6 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 166 | 118 | 6 | dd5944101ef58a9a29aa3eb5c17690119572b8f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 166 | 118 | 6 | 8e5e8de51b4dacdadaa5a08279df30b5c7ed3628 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-06 | 171 | 118 | 6 | ed5886d6aa87b2d73469d39dc217227bd4d4c918 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.54e-06 | 176 | 118 | 6 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-06 | 177 | 118 | 6 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.79e-06 | 177 | 118 | 6 | 47813ad05527ea583e736b54b7a48f7ad90c3aef | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 8.85e-06 | 181 | 118 | 6 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 182 | 118 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.42e-06 | 183 | 118 | 6 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.42e-06 | 183 | 118 | 6 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-05 | 185 | 118 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 186 | 118 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-05 | 186 | 118 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.07e-05 | 187 | 118 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 188 | 118 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.10e-05 | 188 | 118 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 188 | 118 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 189 | 118 | 6 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 189 | 118 | 6 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-05 | 189 | 118 | 6 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 189 | 118 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 189 | 118 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 118 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 118 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-05 | 192 | 118 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 192 | 118 | 6 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 193 | 118 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 193 | 118 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.27e-05 | 193 | 118 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 193 | 118 | 6 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 193 | 118 | 6 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-05 | 113 | 118 | 5 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-05 | 194 | 118 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 194 | 118 | 6 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 195 | 118 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.35e-05 | 195 | 118 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 195 | 118 | 6 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 195 | 118 | 6 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.39e-05 | 196 | 118 | 6 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-05 | 196 | 118 | 6 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 197 | 118 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.47e-05 | 198 | 118 | 6 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 198 | 118 | 6 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 199 | 118 | 6 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-05 | 199 | 118 | 6 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-05 | 199 | 118 | 6 | f1d5808ccb1d5d4e2d34f864e705e2484000e88f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Macroglial-Astrocyte|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 75f5ea38fbd341b80a8058077a04447f0e0eea28 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 118 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.70e-05 | 203 | 118 | 6 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.86e-05 | 66 | 118 | 4 | 85e0027bf0d4ebdcb6cac358aedd1d74aa83c612 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.86e-05 | 66 | 118 | 4 | 6cf03dd1db7607684cdcca7df08933f8cdc3adef | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-05 | 135 | 118 | 5 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 135 | 118 | 5 | 5113bb1713f99d01103b9a99de5d80393081cf87 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.34e-05 | 138 | 118 | 5 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.58e-05 | 140 | 118 | 5 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.24e-05 | 145 | 118 | 5 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.67e-05 | 148 | 118 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 6.00e-05 | 156 | 118 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.18e-05 | 157 | 118 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.37e-05 | 158 | 118 | 5 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.76e-05 | 160 | 118 | 5 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 160 | 118 | 5 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.17e-05 | 162 | 118 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 164 | 118 | 5 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 164 | 118 | 5 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 164 | 118 | 5 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 166 | 118 | 5 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 8.05e-05 | 166 | 118 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 8.28e-05 | 167 | 118 | 5 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 168 | 118 | 5 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.51e-05 | 168 | 118 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.75e-05 | 169 | 118 | 5 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 169 | 118 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Fos_(Layer_5,_medial_posterior_cortex_(Retrosplenial_cortex_(RSG),_subiculum))-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.84e-05 | 88 | 118 | 4 | a909ea58f17716de9cf2486e648b89298b96e0d1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Fos_(Layer_5,_medial_posterior_cortex_(Retrosplenial_cortex_(RSG),_subiculum))|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.84e-05 | 88 | 118 | 4 | e38bee67177403cc06714b98e824a17055204586 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 170 | 118 | 5 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 9.00e-05 | 170 | 118 | 5 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| Drug | monatepil | 7.35e-09 | 29 | 118 | 6 | CID000060810 | |
| Drug | pitavastatin | 2.19e-06 | 114 | 118 | 7 | CID005282451 | |
| Drug | Hypertensin II | AMHR2 RPS6KA4 NOX3 TNFRSF11A ACVR2A ACVR2B KCNB2 LRP1B ITGB3 DST LRP1 TNFAIP3 | 2.42e-06 | 429 | 118 | 12 | CID000025476 |
| Drug | GRGDTP | 7.46e-06 | 8 | 118 | 3 | CID004644096 | |
| Drug | ezetimibe | 1.17e-05 | 147 | 118 | 7 | CID000150311 | |
| Drug | G-P-G | 2.20e-05 | 32 | 118 | 4 | CID000485267 | |
| Drug | probucol | 2.21e-05 | 162 | 118 | 7 | CID000004912 | |
| Drug | ethylnylestradiol | AMHR2 VWF IRF7 WDR5 TNFRSF11A ACVR2A ACVR2B LRP1B F12 MTA3 LRP10 LPA LRP1 LRP2 LRP4 TNFAIP3 DMBT1 LPAL2 TUBAL3 | 2.29e-05 | 1251 | 118 | 19 | CID000003285 |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 2.66e-05 | 2 | 118 | 2 | ctd:C561635 | |
| Drug | AC1L1J6H | 3.25e-05 | 236 | 118 | 8 | CID000004889 | |
| Drug | 17alpha-estradiol | WNT7A SLCO1B3 TNFRSF11A ACVR2B SLCO1B1 LRP1B ITGB3 CLCN3 PSME4 PTPRE MTA3 LRP10 LPA LRP1 LRP2 LRP4 UHRF1 TNFAIP3 TUBAL3 | 4.00e-05 | 1303 | 118 | 19 | CID000000450 |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 5.89e-07 | 5 | 116 | 3 | DOID:2741 (implicated_via_orthology) | |
| Disease | response to statin | 2.80e-06 | 56 | 116 | 5 | GO_0036273 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.27e-06 | 8 | 116 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.89e-06 | 9 | 116 | 3 | EFO_0800562 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 1.53e-05 | 2 | 116 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 1.53e-05 | 2 | 116 | 2 | C0220991 | |
| Disease | Rotor syndrome | 1.53e-05 | 2 | 116 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 1.53e-05 | 2 | 116 | 2 | 237450 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.65e-05 | 13 | 116 | 3 | EFO_0800474 | |
| Disease | Proteinuria | 2.60e-05 | 15 | 116 | 3 | HP_0000093 | |
| Disease | glucoside xylosyltransferase 1 measurement | 4.58e-05 | 3 | 116 | 2 | EFO_0801629 | |
| Disease | urate measurement | RPS6KA4 PRELID1 GLIS3 GON4L ACVR2A CUBN SLCO1B1 GLI1 TGFBRAP1 LRP1 LRP2 LRP4 UHRF1 | 5.22e-05 | 895 | 116 | 13 | EFO_0004531 |
| Disease | X-23756 measurement | 1.52e-04 | 5 | 116 | 2 | EFO_0022126 | |
| Disease | Hydrophthalmos | 1.52e-04 | 5 | 116 | 2 | C0020302 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.70e-04 | 70 | 116 | 4 | EFO_0008082 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 2.27e-04 | 6 | 116 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | Common Migraine | 3.18e-04 | 7 | 116 | 2 | C0338480 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 3.18e-04 | 7 | 116 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.75e-04 | 239 | 116 | 6 | EFO_0010934 | |
| Disease | deoxycholic acid glucuronide measurement | 4.22e-04 | 8 | 116 | 2 | EFO_0800575 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 4.22e-04 | 8 | 116 | 2 | EFO_0801777 | |
| Disease | Acute Confusional Migraine | 5.42e-04 | 9 | 116 | 2 | C0521664 | |
| Disease | Status Migrainosus | 5.42e-04 | 9 | 116 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 5.42e-04 | 9 | 116 | 2 | C0270858 | |
| Disease | tetradecanedioate measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0021057 | |
| Disease | Sick Headaches | 5.42e-04 | 9 | 116 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 5.42e-04 | 9 | 116 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 5.42e-04 | 9 | 116 | 2 | C0018984 | |
| Disease | X-21467 measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0020007 | |
| Disease | creatinine measurement | SEMA7A WNT7A GLIS3 ACVR2A ACVR2B CUBN PLXNB2 F12 LPA LRP2 MEGF10 DCAF12 | 5.58e-04 | 995 | 116 | 12 | EFO_0004518 |
| Disease | myocardial infarction (is_implicated_in) | 6.40e-04 | 99 | 116 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | Marfan syndrome (implicated_via_orthology) | 6.75e-04 | 10 | 116 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | asthma | DPP4 GLIS3 TNFRSF11A PRAG1 LRP1B CRB1 TM9SF2 TGFBRAP1 LRP1 TRPM8 | 7.77e-04 | 751 | 116 | 10 | MONDO_0004979 |
| Disease | cholestasis (biomarker_via_orthology) | 9.56e-04 | 49 | 116 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Thromboembolism | 9.86e-04 | 12 | 116 | 2 | C0040038 | |
| Disease | cystatin C measurement | 1.08e-03 | 402 | 116 | 7 | EFO_0004617 | |
| Disease | IGFBP-1 measurement | 1.16e-03 | 13 | 116 | 2 | EFO_0005118 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.16e-03 | 13 | 116 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Migraine Disorders | 1.16e-03 | 13 | 116 | 2 | C0149931 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.16e-03 | 13 | 116 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Polydactyly | 1.19e-03 | 117 | 116 | 4 | C0152427 | |
| Disease | Anilide use measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0009938 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 1.56e-03 | 15 | 116 | 2 | EFO_0022328 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0007804, GO_0036273 | |
| Disease | t-tau measurement | 1.57e-03 | 126 | 116 | 4 | EFO_0004760 | |
| Disease | acylcarnitine measurement | 1.62e-03 | 127 | 116 | 4 | EFO_0005059 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.64e-03 | 59 | 116 | 3 | EFO_0022260 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.77e-03 | 16 | 116 | 2 | C0751885 | |
| Disease | migraine without aura, susceptibility to, 4 | 1.77e-03 | 16 | 116 | 2 | MONDO_0011847 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.89e-03 | 62 | 116 | 3 | EFO_0022306 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.98e-03 | 63 | 116 | 3 | EFO_0022292 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.00e-03 | 17 | 116 | 2 | C0751883 | |
| Disease | X-21441 measurement | 2.00e-03 | 17 | 116 | 2 | EFO_0800814 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.00e-03 | 17 | 116 | 2 | EFO_0022232 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis | 2.00e-03 | 17 | 116 | 2 | EFO_0004276, EFO_0004775 | |
| Disease | Female Urogenital Diseases | 2.25e-03 | 18 | 116 | 2 | C1720887 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.51e-03 | 19 | 116 | 2 | C0751884 | |
| Disease | type 1 diabetes mellitus | 2.73e-03 | 242 | 116 | 5 | MONDO_0005147 | |
| Disease | citrulline measurement | 2.78e-03 | 20 | 116 | 2 | EFO_0009777 | |
| Disease | uric acid measurement | 2.87e-03 | 610 | 116 | 8 | EFO_0004761 | |
| Disease | Prostatic Neoplasms | 3.05e-03 | 616 | 116 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.05e-03 | 616 | 116 | 8 | C0376358 | |
| Disease | Antimigraine preparation use measurement | 3.06e-03 | 21 | 116 | 2 | EFO_0009939 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.06e-03 | 21 | 116 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 3.06e-03 | 21 | 116 | 2 | EFO_0022246 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.06e-03 | 21 | 116 | 2 | EFO_0022262 | |
| Disease | HbA1c measurement, response to sulfonylurea | 3.06e-03 | 21 | 116 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | osteoarthritis, knee | 3.56e-03 | 158 | 116 | 4 | EFO_0004616 | |
| Disease | nicotine dependence | 3.63e-03 | 78 | 116 | 3 | EFO_0003768 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.67e-03 | 23 | 116 | 2 | C0018784 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 3.67e-03 | 23 | 116 | 2 | EFO_0004286, EFO_0004791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSGRELCANLEGSYW | 276 | Q5DID0 | |
| DICCAQFSEDDQWYR | 546 | Q9BXT4 | |
| YCNCDAGRNEWTSDT | 736 | Q9BZ76 | |
| SFCVNDYTWGGSRCQ | 356 | Q63HQ2 | |
| CDQVCDYWRLNSTCL | 356 | Q75V66 | |
| NLKRDDADSYWCGTE | 96 | Q6UXZ3 | |
| WAESRECYNPECTAN | 441 | O60242 | |
| WDENTSAGRYVRENC | 421 | P49760 | |
| QCGLNDETWYILSSC | 201 | P18825 | |
| QGCWLDDINCYDRTD | 76 | P27037 | |
| QDGRTYDSDCWRQQA | 431 | O00468 | |
| YDSDCWRQQAECRQQ | 436 | O00468 | |
| VCNRHWIGSDCNTYF | 701 | Q9P0K1 | |
| YCNCDADRNEWTNDT | 736 | Q9C0A0 | |
| DGCVNTICWNDTGEY | 51 | Q58WW2 | |
| SCYGNESALWECQHR | 116 | Q9NR16 | |
| LYSRCCFGIWNLTQD | 56 | Q16671 | |
| CQREAERCTGASWQF | 126 | Q8TD07 | |
| DQVNCSGAEAYLWDC | 226 | P30203 | |
| CGYTQDLTDNFDWTR | 761 | Q8NFP4 | |
| WRCEDRCEQGTYGND | 176 | Q96KG7 | |
| EQCDAGWLSDQTVRY | 201 | Q96GW7 | |
| CPDWFECENLYSADD | 581 | Q96F46 | |
| QGCWTYGNIRVCVED | 251 | P23469 | |
| QCGCGLYNSQEELNW | 496 | Q9NPJ1 | |
| EWTGQYCTEDVDECQ | 286 | P46531 | |
| ICCSWTNDGQYLALG | 136 | Q9HBG6 | |
| CYSEAQRCDGSWDCA | 331 | Q7Z4F1 | |
| RCLLNTQWQCDGDFD | 2856 | Q9NZR2 | |
| IQSCWNYGFSCSSDE | 486 | Q08380 | |
| YCDKACNNSACDWDG | 451 | Q3T906 | |
| EWAACAGYARDLLCQ | 71 | Q96JK4 | |
| EGYAGIRCENFTTCW | 166 | Q03001 | |
| YRCEASNSAGVDAWE | 1226 | Q8NDA2 | |
| NRCVPGRWQCDYDND | 3546 | Q07954 | |
| QELLCNGYWAFECLT | 861 | Q12766 | |
| WQECQDCAYFGVCQR | 726 | Q86YR7 | |
| TQCRDSQDPYCGWCV | 476 | O15031 | |
| VDCRNTDQTYWCEYR | 61 | Q9BYJ0 | |
| WSECSRTCGEGYQFR | 631 | Q86TH1 | |
| DICDYDESSGRWNCL | 326 | P27487 | |
| SVYETDCRWDGCSQE | 231 | P08151 | |
| LAQQGYDESCDLWSL | 581 | O75676 | |
| GSGAWEACSNCIEAY | 236 | O75949 | |
| SGRCIYQNWVCDGED | 231 | P98164 | |
| CYEGLQWLDEARTCF | 26 | Q92985 | |
| CGVSNFEQYTGDDCW | 596 | Q8IYI6 | |
| TKNSYWQCSECDQAG | 766 | O94880 | |
| NSWTQDNGCTLCEFD | 271 | O00469 | |
| YFLCNSWLSINVGDC | 1486 | Q7Z442 | |
| ESCEICQEQFEQYWD | 1441 | O94913 | |
| WQGNGYICEDINECE | 296 | O60494 | |
| EQWRERADSAACCDY | 121 | O14531 | |
| WGIDEIYLESCCQAR | 126 | Q92953 | |
| VCGWYNITDFSGECQ | 1741 | Q4AC94 | |
| NADCSYVRAQDWAAI | 206 | Q92874 | |
| DWSLDCCSGYEGDQE | 606 | P41002 | |
| CRENVCLAYGSEWSV | 296 | Q5T6F0 | |
| GREDIVYSVTCEQCW | 356 | P29317 | |
| CCRWIDCSALYDQQE | 346 | Q8NEA6 | |
| ELRAQECLPYAAWCQ | 56 | P23610 | |
| CGEWTYNPLEQCCDD | 36 | Q6B9Z1 | |
| AECQEGLSENSACRW | 1276 | Q3T8J9 | |
| AYDLWREENGCECTK | 186 | Q8J025 | |
| RWEYCNLTQCSDAEG | 96 | P08519 | |
| DPGVRWEYCNLTQCS | 206 | P08519 | |
| WEYCNLTQCSDAEGT | 211 | P08519 | |
| PGVRWEYCNLTQCSD | 321 | P08519 | |
| GVRWEYCNLTQCSDA | 436 | P08519 | |
| VRWEYCNLTQCSDAE | 551 | P08519 | |
| RWEYCNLTQCSDAEG | 666 | P08519 | |
| DPGVRWEYCNLTQCS | 776 | P08519 | |
| WEYCNLTQCSDAEGT | 781 | P08519 | |
| PSVRWEYCNLTQCSD | 891 | P08519 | |
| SVRWEYCNLTRCSDA | 1006 | P08519 | |
| WEYCNLTQCSETESG | 1571 | P08519 | |
| LAWECDYRREAACAQ | 281 | Q96D53 | |
| KLQCNGYNDCDDWSD | 286 | Q9Y5Q5 | |
| YTECCCQDGEAWSQQ | 1606 | Q14767 | |
| TCEKAADNYECNRWA | 51 | Q86Y78 | |
| GWLGSQCECSEEDYR | 491 | P05106 | |
| VTGLACDRCADGYWN | 1056 | A4D0S4 | |
| ENDPRNCCYLWAVQS | 276 | Q8WYP5 | |
| ACRWVDCCAAYEQQE | 196 | Q8NBF1 | |
| YSGVNCELEIDECWS | 216 | P82279 | |
| GTVCDDYWDTNDANV | 256 | Q9UGM3 | |
| VCDDYWDTNDANVVC | 1146 | Q9UGM3 | |
| CDDYWDTNDANVVCR | 1276 | Q9UGM3 | |
| GTVCDDYWDTNDANV | 1531 | Q9UGM3 | |
| YCNCDAGQNEWTSDT | 736 | Q96NU0 | |
| EQVLACWSDCRFYPA | 91 | Q9BVI0 | |
| GRACESCYATQSHQW | 376 | Q9BTC8 | |
| NRDRLSWEYCDLAQC | 281 | P00748 | |
| IEWCCSVCREYFQNG | 96 | Q1RMZ1 | |
| RWEYCNLTRCSDDEG | 96 | Q16609 | |
| KGDNASNCDCRAWDY | 191 | A1A5C7 | |
| SNCDCRAWDYGIRAG | 196 | A1A5C7 | |
| RCVYCVNSDNSGWTE | 111 | Q9Y255 | |
| QAGIQIGDACWELYC | 11 | A6NHL2 | |
| YCNSECNCDESQWEP | 411 | G3V0H7 | |
| TFCWDCCQESIEQDY | 206 | Q8TBB0 | |
| FCRDRYAEWQTVAQC | 241 | Q9HBY0 | |
| LSYCNSDCNCDESQW | 456 | Q9Y6L6 | |
| GCWLDDFNCYDRQEC | 76 | Q13705 | |
| QCCWGSNETTFEERD | 171 | P51790 | |
| RGRWACQSCTFENEA | 351 | Q96EP0 | |
| QDFAAAEDYCLWCSE | 691 | Q8WUH2 | |
| VCQDDWNENYGRAAC | 171 | O15393 | |
| ALCRCQTGWHVYNDS | 521 | Q9UK80 | |
| IDFAQEYWSCCGARG | 146 | Q96FV3 | |
| ECEWRYNSCAPACQV | 1141 | P04275 | |
| EFVETGLCYDTRNWN | 151 | P21580 | |
| VYRCTSCNWDFRNET | 751 | Q96K83 | |
| LSYCNSECNCDESQW | 456 | Q9NPD5 | |
| LYRLDLDGNGWTCDC | 351 | Q7L0X0 | |
| GYWDCSVCTFRNSAE | 21 | Q8IY57 | |
| CGWDQGRCISIYSSE | 511 | O75326 | |
| ESGDDSWDLITCYCR | 331 | Q9BUL5 | |
| GVELEDWLCCQYLAS | 1376 | Q86YV5 | |
| YNDWGACIATSCESR | 1421 | Q14997 | |
| AARLYLEDTGCWDTN | 261 | P41587 | |
| YGLECSSFQDDWECR | 111 | Q96NG8 | |
| NCCNTSTVADAYRWR | 596 | Q9ULQ1 | |
| DEWYCPECRNDASEV | 356 | Q96T88 | |
| VTWCYDVEDGQRFCN | 161 | Q99805 | |
| DECQFQFRNGRWNCS | 71 | O00755 | |
| ICNNFWESCDLQGYS | 1036 | Q9BXT5 | |
| YSCEAWGGSNCLELA | 646 | Q7Z2W7 | |
| YDGLCRIWDTASGQC | 191 | P61964 | |
| RDSDRYCGLCAAWFN | 141 | Q9H898 | |
| RFCWQLPETDYECTN | 126 | Q9BRN9 | |
| RSWQADSVDSGCSNC | 811 | Q9ULE0 | |
| AGYHWSQDCECCRRN | 116 | Q9Y6Q6 | |
| CNNTDASADWCEIFG | 81 | B1ANS9 | |
| NACREEYWLQTCSPF | 681 | P57678 | |
| NSEGAFQCWCETGYE | 411 | O75096 |